Chronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis

Similar documents
Donor Quality Assessment

NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME

U.S. changes in Kidney Allocation

New Zealand Kidney Allocation Scheme

Pathology. Consortium of renal pathologist. Pathologists

Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients

SELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%

User Guide. A. Program Summary B. Waiting List Information C. Transplant Information

The number of patients on the active liver transplant list at 31 March 2017 was 530, a fall of 8% from 2016

BK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy

INTERIM REPORT ON KIDNEY TRANSPLANTATION

Organ utilisation: where are we?

NHS BLOOD AND TRANSPLANT LIVER ADVISORY GROUP WAITING TIMES AND DEATHS ON THE LIST BY BLOOD GROUP SUMMARY

The number of patients registered on the kidney transplant list this year fell by 7% from 5686 to 5275

The number of patients waiting on the pancreas transplant list fell by 7% during the year, to 252 at 31 March 2015

Downloaded from:

The number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033

The number of patients waiting on the pancreas transplant list fell by 1% during the year, to 224 at 31 March 2017

Scores in kidney transplantation: How can we use them?

National on-call pathology service to support Tx. The story so far and vision for the future

lnhs BLOOD AND TRANSPLANT RESEARCH, INNOVATION AND NOVEL TECHNOLOGIES ADVISORY GROUP DCD HEART ACTIVITY

Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys?

Renal Transplant Registry Report 2008

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Are two better than one?

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

Manchester Royal Infirmary Renal & Pancreas Transplant Unit / 2011 Activity Annual Report

Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review

NHS BLOOD AND TRANSPLANT ORGAN DONATION & TRANSPLANTATION DIRECTORATE

NHS BLOOD AND TRANSPLANT ORGAN DONATION & TRANSPLANTATION DIRECTORATE

ABO mismatched Renal Transplants

Impact of symptomatic UTI on long term transplant function

egfr > 50 (n = 13,916)

Heart Transplantation & MCS in 2017 Advances & Challenges

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

Hasan Fattah 3/19/2013

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

out of hours donor frozen section

Transplant Update New Kidney Allocation System Transplant Referral Strategies. Antonia Harford, MD University of New Mexico

Causes of renal allograft failure in the UK: trends in UK Renal Registry and National Health Service Blood and Transplant data from 2000 to 2013

Summary of Significant Changes. Policy

UK Liver Transplant Audit

Paired Donation. Andrew Bradley Rachel Johnson Joanne Allen Susan V Fuggle. Cambridge University NHS Hospitals NHS Foundation trust

NHS BLOOD AND TRANSPLANT ORGAN DONATION & TRANSPLANTATION DIRECTORATE

Overview of organ donation and transplantation

Transplant Center Quality Assessment Using a Continuously Updatable, Risk-Adjusted Technique (CUSUM)

PARTICULARS, SCHEDULE 2 THE SERVICES, A SERVICE SPECIFICATION. A03/S(HSS)/a Pancreas transplantation service (Adult)

Organ Donation Activity

Steroid Minimization: Great Idea or Silly Move?

The New Kidney Allocation Policy: Implications for Your Patients and Your Practice

Transplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation

DCD Heart Transplantation Papworth Perspective

Prof. Armando Torres Nephrology Section Hospital Universitario de Canarias University of La Laguna Tenerife, Canary Islands, Spain.

Utilisation of an embedded specialist nurse and collaborative care pathway increases potential organ donor referrals in the emergency department

Title:Impaired renal function and associated risk factors in newly diagnosed HIV-infected Adults in Gulu Hospital, Northern Uganda

Debate: HLA matching matters in children

This report has been produced by Statistics and Clinical Audit, NHS Blood and Transplant.

The CARI Guidelines Caring for Australians with Renal Impairment. Assessment of donors with sub-optimal kidney function/structure GUIDELINES

Kidney Allograft Fibrosis and Atrophy Early After Living Donor Transplantation

Do we need a different organ allocation system for kidney transplants using donors after circulatory death?

TRANSPLANT ACTIVITY IN THE UK

Manchester Royal Infirmary Renal & Pancreas Transplant Unit / 2012 Activity Annual Report

Review of Rituximab and renal transplantation. Dr.E Nemati. Professor of Nephrology

Overview of Organ Donation and Transplantation

Expanded Criteria Recipients: Are there any Limits

INVITED REVIEW. Zero-time renal transplant biopsies: a comprehensive review. Maarten Naesens 1,2. Leuven, Belgium, EU. Corresponding author:

Notes of the Organ Donation and Transplantation in Paediatrics Meeting Wednesday, 15 th July 2015

Impact of ultrasound examination shortly after kidney transplantation

Reduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival

Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

Gabriel C. Oniscu Consultant Transplant Surgeon Honorary Clinical Senior Lecturer NRS Career Research Fellow Royal Infirmary of Edinburgh

Transplant Success in Sensitized Patients Receiving a Standardized Desensitization Therapy: 3 Year Outcomes

This report has been produced by Statistics and Clinical Audit, NHS Blood and Transplant.

Kidney Summary. Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA

Transplant surgery: the latest

Supplementary Material. Serum Chloride is an Independent Predictor of Mortality in Hypertensive Patients

Heart Transplant: State of the Art. Dr Nick Banner

Chapter 6: Transplantation

Chapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Future Webinars. Handouts 18/09/ Program-Handouts.aspx

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

Manchester Royal Infirmary Renal & Pancreas Transplant Unit / 2010 Activity Annual Report

The UK Pancreas Allocation Scheme for Whole Organ and Islet Transplantation

The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.

Transplant Webinar Series: Ep. 9 Biomarkers for Post-Transplant Immune Injury

Short-term and Long-term Survival of Kidney Allograft Cure Model Analysis

Supplementary appendix

ASBMT and Marrow Transplantation

Prof. Rosanna Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy. Slide 1.

Pancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry

Summary of Significant Changes. Policy

The transplant benefit score and the national liver offering scheme

NHS BLOOD AND TRANSPLANT CARDIOTHORACIC ADVISORY GROUP URGENT HEART ALLOCATION SCHEMES 2015/2016 ACTIVITY SUMMARY

Social deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj

Organ perfusion prior to transplantation

The use of ex vivo normothermic perfusion for the resuscitation and assessment of human kidneys discarded because

Zhao Y Y et al. Ann Intern Med 2012;156:

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival


Transcription:

Chronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis Benedict Phillips 1, Kerem Atalar 1, Hannah Wilkinson 1, Nicos Kessaris 1, Naomi Simmonds 2, Theodoros Kasimatis 1, Rachel Hilton 1, Catherine Horsfield 2, Chris Callaghan 1 1 Department of Nephrology and Transplantation, Guy s and St Thomas NHS Foundation Trust, London 2 Department of Histopathology, Guy s and St Thomas NHS Foundation Trust, London

Introduction UK deceased kidney donors have changed significantly over the last decade Increasing utilisation of older donors More kidneys from high risk donors Percentage N= 100 90 80 70 60 50 40 Age of deceased kidney donors in the UK Age of deceased donors in the UK, 1 April 2007-31 March 2017 809 899 959 1010 1088 1212 1320 1282 1364 1413 3 5 8 10 11 12 11 15 13 14 17 15 18 20 23 22 22 23 22 22 24 26 24 23 25 26 25 22 25 24 30 20 48 50 46 42 38 37 37 39 36 36 10 0 5 7 4 4 4 3 4 4 4 4 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 2012-2013 2013-2014 2014-2015 2015-2016 2016-2017 Age 0-17 18-49 50-59 60-69 70+ Annual report on kidney transplantation 2016/2017, NHSBT Source: Transplant activity in the UK, 2016-2017, NHS Blood and Transplant

Introduction UK deceased kidney donors have changed significantly over the last decade Increasing utilisation of older donors UK Kidney Donor Risk Index of DBD donor kidney transplants More kidneys from high risk donors Annual report on kidney transplantation 2016/2017, NHSBT

Introduction More accurate donor risk assessment tools are needed to inform utilisation decisions and to enable appropriate recipient selection Registry-based donor risk indices KDRI Rao et al, Transplantation 2009 UKKDRI Watson et al, Transplantation 2012 New UKKDRI Mumford et al, unpublished

Introduction More accurate donor risk assessment tools are needed to inform utilisation decisions and to enable appropriate recipient selection Chronic changes on kidney biopsy Karpinski Karpinski et al, Transplantation 1999 Remuzzi Remuzzi et al, J Am Soc Nephrol 1999 CADI Nyberg et al, Transplant 2001 Banff Liapis et al, Am J Transplant 2017

Utility of pre-implantation kidney biopsy?

Aims 1. Determine whether chronic donor histological changes at transplantation were predictive of graft outcomes at our centre If so, what histological score thresholds can be used to determine optimal organ selection? 2. Determine whether systematic pre-implantation kidney biopsies would have increased organ utilisation

Methods DATA INCLUSION CRITERIA HISTOPATHOLOGY GROUPS OUTCOMES 10-year period (2005-2015) Retrospective analysis Single-centre Follow-up period: 5 years or 20 January 2018 STATISTICS UTILISATION ANALYSIS

Methods DATA INCLUSION CRITERIA HISTOPATHOLOGY GROUPS Deceased donor: DBD & DCD Single kidney-only transplants Adult recipients OUTCOMES STATISTICS UTILISATION ANALYSIS

Methods DATA INCLUSION CRITERIA HISTOPATHOLOGY GROUPS OUTCOMES STATISTICS UTILISATION ANALYSIS Biopsies taken on the day of transplantation 16G core biopsy: formalin fixed, paraffin embedded Staining: H&E, PAS, PAMS and Masson trichrome Karpinski (K) score by renal histopathologists o Scored 0-12 ( 20 glomeruli) o Based on glomerular, tubular, interstitial and vascular components (each 0-3) K score not known at the time of transplantation

Methods DATA INCLUSION CRITERIA HISTOPATHOLOGY GROUPS OUTCOMES STATISTICS Compare low vs high K score at two thresholds K score 0-3 vs 4-12 K score 0-4 vs 5-12 UTILISATION ANALYSIS

Methods DATA INCLUSION CRITERIA HISTOPATHOLOGY GROUPS OUTCOMES STATISTICS Graft function (4-variable MDRD egfr) Death-censored graft survival (DCGS) Patient survival UTILISATION ANALYSIS

Methods DATA INCLUSION CRITERIA HISTOPATHOLOGY GROUPS OUTCOMES STATISTICS UTILISATION ANALYSIS Normality Shapiro-Wilk Q-Q plots Demographic comparisons Student T test Mann-Whitney test χ 2 test Correlation analysis Spearman s rho Kaplan Meier survival Log rank Multivariate analysis Linear regression Cox regression

Methods DATA INCLUSION CRITERIA HISTOPATHOLOGY GROUPS OUTCOMES STATISTICS UTILISATION ANALYSIS Examine organ utilisation at our centre 2012-2015, DBD and DCD, donors 60+ years Single and dual transplants, adult recipients Retrospectively determine organ utilisation had we known the kidney biopsy result pre-operatively, using 0-4 / 5-6 / 7+ thresholds

Results All single adult kidney-only transplants 2005-2015 n = 844 No biopsy n = 256 (30%) Time zero kidney biopsy performed n = 588 (70%) Inadequate biopsy (<20 glomeruli) n = 180 (31%) Adequate biopsy ( 20 glomeruli) n = 408 (69%)

Results: donor / recipient groups DONOR characteristics Adequate biopsy (n=408) No or inadequate biopsy (n=436) p value RECIPIENT characteristics Adequate biopsy (n=408) Donor age (years) 51 (41-60) 50 (43-64) 0.38 Recipient age (years) 50 (42-59) Donor gender Male Female Donor type DBD DCD Cause of death Stroke Trauma Other UKKDRI 1.35 >1.35 (high risk) 210 (51.5%) 198 (48.5%) 274 (67.2%) 134 (32.8%) 241 (59.1%) 40 (9.8%) 127 (31.1%) 1.04 (0.97-1.46) 261 (65.6%) 137 (34.4%) 222 (50.9%) 214 (49.1%) 292 (67.0%) 144 (33.0%) 241 (55.3%) 38 (8.7%) 157 (36%) 1.04 (0.98-1.49) 227 (62.4%) 137 (37.6%) 0.87 0.96 0.32 0.22 0.36 Cold ischaemia time (mins) 840 (660-1027) 900 (690-1050) 0.46 Data are expressed as number (%), median (IQR) Recipient gender Male Female Recipient ethnicity White Black Other Primary renal disease Diabetes mellitus Hypertension Other Graft number 1 >1 HLA mismatch level 1 2 3 4 258 (63.2%) 150 (36.8%) 232 (56.9%) 124 (30.4%) 52 (12.7%) 41 (10.0%) 73 (17.9%) 294 (72.1%) 344 (84.3%) 64 (15.7%) 55 (14%) 130 (33%) 188 (47%) 26 (6%)

Number of values Number of values K score Results: K score distribution 80 80 60 60 40 40 20 20 0 Histogram of K score distribution Histogram of K score distribution 0 0 0 1 1 2 2 3 3 4 4 5 5 score K score 6 6 7 7 8 8 10 8 6 4 2 0 0 Donor age versus K score 20 40 Spearman s rho = + 0.54 p < 0.001 60 Donor age 80 100

Year 1 egfr (ml/min/1.73 2 ) Results: K score and graft function (1) 1 year egfr versus K score 1 year egfr (n=370) 3 year egfr (n=256) (n=256) 5 year egfr (n=141) K score 43 K score 54 p value 52 (41-67) (38-66) 43 41 (32-55) (32-54) <0.001 56 53 (46-68) (45-67) 48 46 (34-61) (33-58) <0.001 52 51 (40-63) (37-63) 46 45 (34-64) (34-66) 0.12 0.35 Data are expressed as median (IQR), ml/min/1.73m 2 Graft failures excluded 1 year egfr (ml/min/1.73m 2) 150 100 50 0 0 1 2 3 4 5 6 7 8 9 10 K score Spearman s rho = - 0.3 (p < 0.001) Weak association

Results: K score and graft function (2) Linear regression analysis Covariates in the equation Predictors of lower graft function at 1 year K score Donor age UKKDRI Recipient age Graft number Transplant type (DBD/DCD) Cold ischaemia time HLA mismatch level For each K score increment egfr drops by 3 ml/min/1.73m 2 (p = 0.02) For each UKKDRI increase by 0.1 egfr drops by 1.5 ml/min/1.73m 2 (p < 0.001) These effects were replicated at 3 years

Results: K score and graft survival (1) (n = 58) (n = 130) (n = 175) (n = 13) Log rank p = 0.72 No significant difference

Number of values Results: K score and graft survival (2) Histogram of of K K score score distribution distribution 80 60 40 20 (n=188) (n=220) 0 0 1 2 3 4 5 6 7 8 K score K score 3 K score 4 p value Donor age (years) 44 (30-53) 57 (49-63) <0.001 Donor male gender 99 (53%) 111 (53%) 0.70 Donor cause of death Stroke Trauma 100 (53%) 29 (15%) 141 (64%) 11 (5%) 0.001 0.001 UKKDRI 1.01 (0.80-1.09) 1.34 (1.01-1.54) <0.001 Recipient age (yr) 48 (41-57) 52 (44-62) 0.001 Recipient male gender 116 (62%) 142 (65%) 0.60 Cold ischaemia time (min) 804 (649-1005) 843 (529-1028) 0.28 Log rank p = 0.26 No significant difference

Number of values Results: K score and graft survival (3) Histogram of of K K score score distribution distribution 80 60 40 20 (n=279) (n=129) 0 0 1 2 3 4 5 6 7 8 K score 4 K score 5 p value Donor age (yr) 49 (35-57) 58 (50-66) <0.001 Donor male gender 143 (51%) 67 (52%) 0.92 Donor cause of death Stroke Trauma 115 (41%) 32 (11%) K score 86 (67%) 8 (6%) 0.73 0.73 UKKDRI 1.02 (0.83-1.28) 1.39 (1.01-1.85) <0.001 Recipient age (yr) 49 (40-58) 54 (46-63) 0.005 Recipient male gender 116 (42%) 92 (71%) 0.02 Cold ischaemia time (min) 810 (641-1020) 866 (643-1011) 0.48 Log rank p = 0.14 No significant difference

Results: K score and graft survival (4) Karpinski score Interstitial score (n = 179) (n = 225) (n = 3) Tubular score (n = 117) (n = 287) (n = 3) Interstitial Tubular Glomerular Vascular K score component Association with death censored graft survival? p value Interstitial 0.31 Glomerular score (n = 103) (n = 289) (n = 14) (n = 1) Vascular score (n = 61) (n = 161) (n = 131) (n = 54) Tubular 0.33 Glomerular 0.78 Vascular 0.31

Results: K score and graft survival (5) Donors aged 50+ years Donors aged 60+ years (n=68) (n=163) (n=19) (n=84) Log rank p = 0.89 No significant difference Log rank p = 0.55 No significant difference (n=131) (n=100) (n=43) (n=60) Log rank p = 0.27 No significant difference Log rank p = 0.24 No significant difference

Results: predictors of DCGS Cox regression analysis Covariates in the equation Independent predictors of DCGS K score Donor age UKKDRI Recipient age Graft number Transplant type (DBD/DCD) Cold ischaemia time HLA mismatch level K score does not predict DCGS (p = 0.60) Graft number >1 only predictor of DCGS (p < 0.001)

Results: primary non-function (PNF) Death-censored graft survival Does K score predict PNF? o PNF defined as graft survival of zero (n=279) (n=129) days, regardless of cause Multivariate analysis: o K score 5 is an independent predictor of PNF (HR 3.5, p = 0.04)

Results: patient survival Patient survival stratified by K score 3 vs 4 Patient survival stratified by K score 4 vs 5 (n=188) (n=220) (n=188) (n=220) Log rank p = 0.64 No significant difference Log rank p = 0.25 No significant difference

Results: impact on organ utilisation Clinically acceptable kidneys 2012 to 2015 Donors 60 years Adequate time zero biopsy Single 73 kidneys 73 recipients Median 1 year egfr 38 1 year DCGS 90% Dual 40 kidneys 20 recipients Median 1 year egfr 51 1 year DCGS 88% Utilisation algorithm Single kidney transplant(s)? One kidney at our centre? K score 0-4 SINGLE K score 5+ DECLINE Both kidneys at our centre? Both K scores 0-4 SINGLE Highest K score 5-6 DUAL Highest K score 7-12 DECLINE Single 54 kidneys 54 recipients Dual 30 kidneys 15 recipients Decline 29 kidneys Dual kidney transplant? Both K scores 0-4 SINGLE x 2 TOTAL 113 kidneys 93 recipients Highest K score 5-6 DUAL Highest K score 7-12 DECLINE TOTAL 84 kidneys 69 recipients

Conclusions Kidneys with K scores 0 to 8 have been implanted as single grafts with good results For every increment in K score, there is a 3 ml/min/1.73m 2 drop in egfr at 1- and 3- years There is no association between K score and medium-term DCGS Independent predictor of primary non-function Retrospective application of a clinico-pathological tool to our programme suggests that organ utilisation would have decreased These data do not support the widespread use of PIKB in our deceased donor kidney programme, given our current donor risk profile

Acknowledgments Surgical colleagues o Geoff Koffman, John Taylor, Francis Calder, Nizam Mamode, Jonathon Olsburgh, Martin Drage, Ioannis Loukopoulos, Nikolaos Karydis Histopathology colleagues o Patrick O Donnell, Fahim Tungekar, Robert Hangartner, Ran Perera Patrick Trotter, NHS Blood and Transplant Donors, recipients, and their families #kidneytransplantbiopsy

Appendix 1: DCGS in high UKKDRI donors DCGS in patients with UKKDRI 1.35 DCGS in patients with UKKDRI 1.50 n=62 n=75 n=39 n=55

3 Year egfr 5 Year egfr Appendix 2: K score and graft function 3 year egfr according to K score 5 year egfr according to K score 150 100 Spearman s rho = - 0.3 (p<0.001) Weak association 150 100 No correlation 50 50 0 0 1 2 3 4 5 6 7 8 9 10 0 0 1 2 3 4 5 6 7 8 9 10 K score K score

Donor age Appendix 3: donor and recipient age 100 80 Donor and recipient age match 60 40 20 0 0 20 40 60 80 100 Recipient age

Appendix 4: DSGS at Guy s (registry data) First graft survival post-transplantation, 2006-2010 First graft survival post-transplantation, 2011-2016 87% 88%

Number of globermuli on single biopsy sample Appendix 5 Biopsy adequacy rates Punch biopsy 16G Core biopsy Number of values 16 576 Minimum 28 0 25% Percentile 35.25 17 Median 42 25 75% Percentile 45.25 35 Maximum 65 97 100 50 Number of glomeruli: punch vs core biopsy 16G Core biopsy Punch biopsy Shipiro-Wilk test of normality Non-parametric Mann-Whitney test comparing both medians Fisher s exact test comparing adequacy p = <0.001 p = 0.005 0 16G Core biopsy Punch biopsy

Appendix 6: Time-zerO Biopsy Investigators (TOBI) National, multi-centre, retrospective analysis of biopsies of deceased donor kidneys Re-analysis of time-zero or pre-implantation kidney biopsies 1.1.08-1.1.16 by multiple blinded renal pathologists Linkage to the national transplant registry to capture donor / recipient variables and determine patient outcomes Aims: 1) determine association between chronic changes at the time of transplantation and subsequent graft and patient outcomes 2) determine the most accurate histological and/or clinico-histopathological scoring systems 3) better define inter-observer variability between renal pathologists Group Chris Callaghan, transplant surgeon, London Candice Roufosse, pathologist, London Rachel Johnson, statistician, NHSBT Desley Neil, pathologist, Birmingham Gavin Pettigrew, transplant surgeon, Cambridge Rachel Hilton, nephrologist, London Next steps Combination of Guy s and Cambridge databases and re-analysis via the national transplant registry Exchange historical slides between Guy s and Cambridge renal histopathologists for blinded scoring Broaden TOBI group and invite interested UK renal transplant centres to join Funding application (NIHR RfPB)

Appendix 7: Graft survival: DBD vs DCD 274 DBDs vs.134 DCDs Overall, DCGS was the same between DBDs and Log rank p = 0.02 K score 5 associated with DCGS in DBDs DCDs (p=0.99) No association between K score and DCGS in DCDs (p=0.50) Association between K score and DCGS in DBDs (p=0.02) o Association lost if PNF patients removed Log rank p = 0.50 No significant difference

Appendix 8: Graft survival: DBD vs DCD 274 DBDs vs.134 DCDs Overall, DCGS was the same between DBDs and DCDs (p=0.99) PNF patients removed Log rank p = 0.33 No significant difference No association between K score and DCGS in DCDs (p=0.50) Association between K score and DCGS in DBDs (p=0.02) o Association lost if PNF patients removed PNF patients removed Log rank p = 0.23 No significant difference

Percentage Percentage of kidneys biopsied 100 80 60 40 20 0 2006 2008 2010 2012 2014 Year

Results: impact on organ utilisation Clinically acceptable kidneys 2012 to 2015 Donors 60 years Adequate time zero biopsy Single 73 kidneys 73 recipients Median 1 year egfr 38 ml/min/1.73m 2 1 year DCGS 90% Dual 40 kidneys 20 recipients Median 1 year egfr 51 ml/min/1.73m 2 1 year DCGS 88% Utilisation algorithm Single kidney transplant(s)? One kidney at our centre? K score 0-4 SINGLE K score 5+ DECLINE Both kidneys at our centre? Both K scores 0-4 SINGLE Highest K score 5-6 DUAL Highest K score 7-12 DECLINE Single 54 kidneys 54 recipients Median 1 year egfr 43 ml/min/1.73m 2 1 year DCGS 90% (n=30) Dual 30 kidneys 15 recipients Median 1 year egfr 51 ml/min/1.73m 2 1 year DCGS 75% (n=8) Decline 29 kidneys Dual kidney transplant? Both K scores 0-4 SINGLE x 2 TOTAL 113 kidneys 93 recipients Highest K score 5-6 DUAL Highest K score 7-12 DECLINE TOTAL 84 kidneys 69 recipients